Skip to main content
Premium Trial:

Request an Annual Quote

Sygnis SunScript Reverse Transcriptases

Sygnis has launched SunScript RT RNaseH+ and SunScript RT RNaseH- enzymes for PCR analysis and the construction of cDNA libraries for use in applications such as next-generation sequencing. The products are based on the company's new SunScript engineered reverse transcriptase, which is derived from HIV-1 and provides extreme thermostability, allowing RT reactions to take place at elevated temperatures of up to 85˚C. Additional advantages include high reaction speed and sensitivity, and the ability to readily transcribe even the longest RNAs from the mammalian genome, Sygnis noted.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.